MARKET

IRIX

IRIX

IRIDEX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.290
+0.290
+14.50%
After Hours: 2.290 0 0.00% 16:00 08/07 EDT
OPEN
2.000
PREV CLOSE
2.000
HIGH
2.500
LOW
2.000
VOLUME
111.83K
TURNOVER
--
52 WEEK HIGH
4.240
52 WEEK LOW
1.220
MARKET CAP
31.58M
P/E (TTM)
-4.2415
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average IRIX stock price target is 4.750 with a high estimate of 5.50 and a low estimate of 4.000.

EPS

IRIX News

More
IRIDEX EPS beats by $0.03, beats on revenue
IRIDEX (NASDAQ:IRIX): Q2 GAAP EPS of -$0.20 beats by $0.03. Revenue of $6.2M (-40.6% Y/Y) beats by $1.16M. Press Release
seekingalpha · 1d ago
IRIDEX Announces Second Quarter 2020 Financial Results
MOUNTAIN VIEW, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 27, 2020. Second Quarter Summary * Total revenue declined 40% to $6.2 million versus $10.4 million i
GlobeNewswire · 2d ago
Analysts Estimate Iridex (IRIX) to Report a Decline in Earnings: What to Look Out for
Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
IRIDEX to Report Second Quarter 2020 Financial Results on August 6, 2020
MOUNTAIN VIEW, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2020 after the close of trading on Thursday, August 6, 2020.  The Company’s manageme
GlobeNewswire · 07/23 20:05
Edited Transcript of IRIX earnings conference call or presentation 11-May-20 9:00pm GMT
Thomson Reuters StreetEvents · 06/16 08:44
APPS, SAVA, PGEN and LPI among midday movers
Seeking Alpha - Article · 06/03 16:42
IRIDEX Corporation (NASDAQ:IRIX) Analysts Are Reducing Their Forecasts For This Year
Simply Wall St. · 05/16 15:05
IRIDEX Corporation (IRIX) CEO David Bruce on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/12 16:52

Industry

Advanced Medical Equipment & Technology
+0.47%
Healthcare Equipment & Supplies
+0.49%

Hot Stocks

Symbol
Price
%Change

About IRIX

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
More

Webull offers kinds of IRIDEX Corporation stock information, including NASDAQ:IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.